Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Stefan K. Barta"'
Autor:
Steven M. Horwitz, Stephen Ansell, Weiyun Z. Ai, Jeffrey Barnes, Stefan K. Barta, Jonathan Brammer, Mark W. Clemens, Ahmet Dogan, Francine Foss, Paola Ghione, Aaron M. Goodman, Joan Guitart, Ahmad Halwani, Bradley M. Haverkos, Richard T. Hoppe, Eric Jacobsen, Deepa Jagadeesh, Allison Jones, Avyakta Kallam, Youn H. Kim, Kiran Kumar, Neha Mehta-Shah, Elise A. Olsen, Saurabh A. Rajguru, Sima Rozati, Jonathan Said, Aaron Shaver, Lauren Shea, Michi M. Shinohara, Lubomir Sokol, Carlos Torres-Cabala, Ryan Wilcox, Peggy Wu, Jasmine Zain, Mary Dwyer, Hema Sundar
Publikováno v:
Journal of the National Comprehensive Cancer Network. 20:285-308
Peripheral T-cell lymphomas (PTCLs) are a heterogeneous group of lymphoproliferative disorders arising from mature T cells, accounting for about 10% of non-Hodgkin lymphomas. PTCL-not otherwise specified is the most common subtype, followed by angioi
Autor:
Aaron C. Shaver, Mark W. Clemens, Mary A. Dwyer, Youn H. Kim, Joan Guitart, Lubomir Sokol, Jeffrey A. Barnes, Jasmine Zain, Basem M. William, Neha Mehta-Shah, Ahmad Halwani, Allison Jones, Carlos A. Torres-Cabala, Ahmet Dogan, Bradley M. Haverkos, Pallawi Torka, Stephen M. Ansell, Eric D. Jacobsen, Gaurav Goyal, Hema Sundar, Ryan A. Wilcox, Sima Rozati, Deepa Jagadeesh, Barbara Pro, Saurabh Rajguru, Aaron M. Goodman, Richard T. Hoppe, Jonathan W. Said, Andrei R. Shustov, Stefan K. Barta, Weiyun Z. Ai, Steven M. Horwitz, Elise A. Olsen
Publikováno v:
Journal of the National Comprehensive Cancer Network. 18:1460-1467
Hepatosplenic T-cell lymphoma (HSTCL) is a rare subtype of T-cell lymphoma associated with an aggressive clinical course and a worse prognosis. HSTCL develops in the setting of chronic immune suppression or immune dysregulation in up to 20% of cases
Autor:
Deepa Jagadeesh, Joan Guitart, Gaurav Goyal, Ahmad Halwani, Eric D. Jacobsen, Richard T. Hoppe, Jasmine Zain, Mary A. Dwyer, Aaron C. Shaver, Jeffrey A. Barnes, Ryan A. Wilcox, Steven M. Horwitz, Ahmet Dogan, Mark W. Clemens, Basem M. William, Elise A. Olsen, Youn H. Kim, Amitkumar Mehta, Stephen M. Ansell, Bradley M. Haverkos, Andrei R. Shustov, Lubomir Sokol, Barbara Pro, Stefan K. Barta, Carlos A. Torres-Cabala, Neha Mehta-Shah, Satish Shanbhag, Weiyun Z. Ai, Pallawi Torka, Hema Sundar, Matthew A. Lunning, Saurabh Rajguru, Aaron M. Goodman, Kristopher R. Fisher
Publikováno v:
Journal of the National Comprehensive Cancer Network. 18:522-536
Mycosis fungoides (MF) is the most common subtype of cutaneous T-cell lymphoma (CTCL), and Sézary syndrome (SS) is a rare erythrodermic and leukemic subtype of CTCL characterized by significant blood involvement. Although early-stage disease can be
Autor:
Evie Carchman, Julian Sanchez, Gita Suneja, Kevin L. Ard, Michelle A. Rudek, Mary A. Dwyer, Oxana V. Crysler, Neel K. Gupta, Allison Hall, David S. Morgan, Chelsea Gustafson, Manoj P. Menon, Lee Ratner, Benjamin Tomlinson, Jeff Taylor, Ann H. Klopp, Nitya Nathwani, Adam L. Cohen, Sai Yendamuri, Stacey A. Rizza, Deborah A. Freedman-Cass, Kimberly L. Johung, Richard F. Ambinder, Ann S. LaCasce, Chia Ching J. Wang, Robert A. Baiocchi, Ariela Noy, Erin Reid, Stefan K. Barta, Chi Lin, Amitkumar Mehta
Publikováno v:
Journal of the National Comprehensive Cancer Network. 17:171-189
As treatment of HIV has improved, people living with HIV (PLWH) have experienced a decreased risk of AIDS and AIDS-defining cancers (non-Hodgkin’s lymphoma, Kaposi sarcoma, and cervical cancer), but the risk of Kaposi sarcoma in PLWH is still eleva
Autor:
Lori J. Maness, Paul J. Shami, Peter Westervelt, H. Joachim Deeg, Virginia M. Klimek, Guillermo Garcia-Manero, Amer M. Zeidan, Hetty E. Carraway, Daniel A. Pollyea, Rami S. Komrokji, John M. Bennett, Karin M.L. Gaensler, Amir T. Fathi, Olga Frankfurt, Peter L. Greenberg, Carlos M. de Castro, Aref Al-Kali, Margaret R. O'Donnell, Lisa Kujawski, Alison Walker, Richard Stone, Robert A. Johnson, Ruth Horsfall, Amy E. DeZern, David R. Head, Elizabeth A. Griffiths, Mark B. Juckett, Rafael Bejar, Dorothy A. Shead, Brady L. Stein, Stefan K. Barta, Courtney Smith
Publikováno v:
Journal of the National Comprehensive Cancer Network. 15:60-87
The myelodysplastic syndromes (MDS) comprise a heterogenous group of myeloid disorders with a highly variable disease course. Diagnostic criteria to better stratify patients with MDS continue to evolve, based on morphology, cytogenetics, and the pres